10/07/2026
π¨ PHARMACY OWNERS: THIS MAY BE OUR 1 SHOT!
CMS is asking for input on what βreasonable and relevantβ PBM practices should look like in Medicare Part D.
This is our opportunity to tell CMS what is really happening: PBM underpayments, unfair contracts, abusive audits, patient steering, restrictive networks, take-it-or-leave-it terms, and excessive payments and markups at PBM-affiliated pharmacies β particularly on high-cost specialty and cancer drugs.
The new federal law, the 2026 Medicare PBM reforms in the Consolidated Appropriations Act,
gives us an opportunity to finally address abusive and unfair PBM practices in Medicare. All 6 members of Arkansasβ congressional delegation voted YES to start this process.
If your pharmacy dispenses Medicare Part D prescriptions, WE NEED YOU TO RESPOND.
π₯ This may be our 1 shot to help rewrite the rules. Tell CMS what PBM practices are doing to your pharmacy, your patients, and prescription drug costs.
Stand up for your pharmacy. Stand up for your patients. Donβt sit this one out. MAKE YOUR VOICE HEARD!
NCPA has prepared a template to make responding easy. It only takes a few minutes:
As you are aware, CMS recently released its long-awaited request for information (RFI) regarding Part D reasonable and relevant contract terms. CMS is seeking public comment, and we need all independent pharmacy owners, regardless of practice...